PEG-based micelles as carriers of contrast agents for different imaging modalities

Advanced Drug Delivery Reviews

Volumn 54, Issue 2, 2002, Pages 235-252

  Torchilin, Vladimir P ^a  

^a NORTHEASTERN UNIVERSITY   (United States)

Author keywords

Amphiphilic co polymers; Contrast agents; Diagnostic imaging; PEG conjugates; Polymeric micelles

Indexed keywords

COPOLYMERS; HYDROPHILICITY; MAGNETIC RESONANCE IMAGING; MICELLES; POLYETHYLENE GLYCOLS;

IMAGING MODALITIES;

DRUG DOSAGE;

AMPHOPHILE; CHELATE; CONTRAST MEDIUM; COPOLYMER; DRUG CARRIER; GADOLINIUM; INDIUM 111; IODINE; LIPID; MACROGOL; METAL; MONOMER; NANOPARTICLE; POLYMER; SURFACTANT;

ARTICLE; CHEMICAL MODIFICATION; CHEMICAL PARAMETERS; CIRCULATION; COMPUTER ASSISTED TOMOGRAPHY; CONJUGATE; DIAGNOSTIC IMAGING; DRUG DELIVERY SYSTEM; DRUG SYNTHESIS; DRUG TARGETING; GAMMA SCINTIGRAPHY; HYDROPHILICITY; IN VITRO STUDY; IN VIVO STUDY; LYMPHATIC SYSTEM; METHODOLOGY; MICELLE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PARTICULATE MATTER; PRIORITY JOURNAL; RABBIT;

ANIMALS; CONTRAST MEDIA; DIAGNOSTIC IMAGING; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; HUMANS; MAGNETIC RESONANCE IMAGING; MICELLES; MICROSPHERES; POLYETHYLENE GLYCOLS; RADIONUCLIDE IMAGING; SURFACE-ACTIVE AGENTS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0037148667     PISSN: 0169409X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-409X(02)00019-4     Document Type: Article

References (84)

1. Magnetic resonance contrast media: Principles and progress
2. Imaging tools: Liposomal agents for nuclear medicine, computed tomography, magnetic resonance, and ultrasound
3. Targeted delivery of imaging agents: An overview
4. Pharmacokinetic considerations in the development of labeled liposomes and micelles for diagnostic imaging
5. Mixed micelles in drug delivery
6. Studies on the reliability of novel absorption-lipophilicity approach to interpret the effects of the synthetic surfactants on drug and xenobiotics absoption
7. Block copolymer micelles as long-circulating drug vehicles
8. Polymer-coated long-circulating microparticulate pharmaceuticals
9. The mechanism of liposome accumulation in infarction
10. Liposome circulation time and tumor targeting: Implications for cancer chemotherapy
11. Tumor vascular permeability and the EPR effect in macromolecular therapeutics: A review
12. How do polymers prolong circulation time of liposomes?
13. Lipid vehicle and formulation effects on intestinal lymphatic drug transport
14. Absorption enhancers
15. Comparative bioavailability studies with a new mixed-micelles solution of diazepam utilizing radioreceptor assay, psychometry and EEG brain mapping
16. The neuroleptic activity of haloperidol increases after its solubilization in surfactant micelles
17. Block copolymers as drug carriers
18. Polymeric micelles: A new generation of colloidal drug carriers
19. Diblock copolymer nanoparticles for drug delivery
20. Thermoresponsive polymer nanoparticles with a core-shell micelle structure as site specific drug carriers
21. Amphiphilic vinyl polymers effectively prolong liposome circulation time in vivo
22. New synthetic amphiphilic polymers for steric protection of liposomes in vivo
23. A new class of drug carriers; micelle poly(oxyethylene)-poly(oxypropylene) block copolymers as microcontainers for drug targeting from blood to brain
24. Interactions of pluronic block copolymers with brain microvessel endothelial cells: Evidence of two potential pathways for drug absorption
25. Characterization and anticancer activity of the micelle-forming polymeric anticancer drug adriamycin-conjugated poly(ethylene glycol)-poly(aspartic acid) block copolymer
26. Novel polyion complex micelles entrapping enzyme molecules in the core. Preparation of narrowly-distributed micelles from lysozyme and poly(ethylene glycol)-poly(aspartic acid) block copolymer in aqueous medium
27. Preparation and characterization of the micelle-forming polymeric drug indomethacin-incorporated poly(ethylene oxide)-poly(β-benzyl-L-aspartate) block copolymer micelles
28. Clonazepam release from core-shell type nanoparticles in vitro
29. Structure and design of polymeric surfactant-based drug delivery systems
30. Block-copolymer micelles as vehicles for drug delivery
31. Block copolymer of polyethylene glycol and polylysine as a carrier of organic iodine: Design of a long circulating particulate contrast medium for X-ray computed tomography
32. Block copolymer micelles for drug delivery: Loading and release of doxorubicin
33. Improved synthesis of adriamycin-conjugated poly(ethylene oxide)-poly(aspartic acid) block copolymer and formation of unimodal micellar structure with controlled amount of physically entrapped adriamycin
34. Biodistribution of micelle-forming polymer-drug conjugates
35. Polymeric micelles as new drug carriers
36. Remarkable increase in nuclease resistance of plasmid DNA through supramolecular assembly with poly(ethyleneglycol)-poly(L-lysine) block copolymer
37. Soluble self-assembled block copolymers for drug delivery
38. Use of polyoxyethylene-lipid conjugates as long-circulating carriers for delivery of therapeutic and diagnostic agents
39. Amphipathic polyethyleneglycols effectively prolong the circulation time of liposomes
40. Phase behavior of 'stealth-lipid' decithin mixtures
41. Polyethylene glycol based micelles as carriers of therapeutic and diagnostic agents
42. Micellar delivery system for dequalinium: A lipophilic cationic drug with anticarcinoma activity
43. New amphipathic polymer-lipid conjugates forming long-circulating reticuloendothelial system-evading liposomes
44. Which polymers can make nanoparticulate drug carriers long-circulating?
45. Amphiphilic poly-N-vinylpyrrolidones: Synthesis, properties and liposome surface modification
46. Enhanced tumor accumulation and prolonged circulation times of micelles-forming poly(ethylene oxide-aspartate) block copolymers-adriamycin conjugates
47. Accumulation of liposomal- and micellar-bound protein in solid tumor
48. Microvascular permeability and interstitial penetration of sterically-stabilized (stealth) liposomes in human tumor xenograft
49. Vascular permeability in a human tumor xenograft: Molecular size dependence and cutoff size
50. Regulation of transport pathways in tumor vessels: Role of tumor type and microenvironment
51. 2 gradients in solid tumors in vivo: High-resolution measurements reveal a lack of correlation
52. Acid pH in tumors and its potential for therapeutic exploitation
53. Effect of molecular architecture of hydrophobically modified poly(N-isopropylacrylamide) on the formation of thermoresponsive core-shell micellar drug carriers
54. Preparation an characterization of thermally responsive block copolymer micelles comprising poly(N-isopropylacrylamide-β-DL-lactide)
55. Copolymers of N-isopropylacrylamide can trigger pH sensitivity to stable liposomes
56. Immunomicelles: Attachment of specific ligands including monoclonal antibodies to polymeric micelles
57. Specific targeting with poly(ethylene glycol)-modified liposomes: Coupling of homing devices to the ends of the polymeric chains combines effective target binding with long circulation times
58. Targetability of novel immunoliposomes modified with amphipathic poly(ethylene glycol)s conjugated at their distal terminals to monoclonal antibodies
59. Attachment of antibodies to sterically stabilized liposomes: Evaluation, comparison and optimization of coupling procedures
60. Targetability of novel immunoliposomes prepared by a new antibody conjugation technique
61. p-Nitrophenylcarbonyl-PEG-PE liposomes: Fast and simple attachment of specific ligands, including monoclonal antibodies, to distal ends of PEG chains via p-nitrophenylcarbonyl groups
62. TAT peptide on the surface of liposomes affords their efficient intracellular delivery even at low temperature and in the presence of metabolic inhibitors
63. Magnetic resonance imaging of the hepatobiliary system: Intestinal absorption studies of manganese mesoporphyrin
64. Synthesis of amphiphilic chelating agents: Bis(hexadecylamide) and bis(octadecylamide) of diethylenetriaminepentaacetic acid
65. A liposomal MRI contrast agent: Phosphatidyl ethanolamine
66. Gadolinium-labeled liposomes containing paramagnetic amphipathic agents: Targeted MRI contrast agent for the liver
67. Manganese-based liposomes. Comparative approaches
68. Mixed micelles containing lipophilic gadolinium complexes as MRA contrast agents
69. Surface engineered nanospheres with enhanced drainage into lymphatics and uptake by macrophages of the regional lymph nodes
70. Stable polymeric micelles: Lymphangiographic contrast media for gamma scintigraphy and magnetic resonance imaging
71. New approaches in the chemical design of Gd-containing liposomes for use in magnetic resonance imaging of lymph nodes
72. Terminal-modified polylysine-based chelating polymers: Highly efficient coupling to antibody with minimal loss in immunoreactivity
73. Poly(ethylene glycol) on the liposome surface: On the mechanism of polymer-coated liposome longevity
74. Polymeric micelles in diagnostic imaging
75. Delivery of diagnostic agents: Achievements and challenges
76. Liposomes as carriers for paramagnetic gadolinium chelates as organ specific contrast agents for magnetic resonance imaging
77. 67Gallium-labeled liposomes with prolonged circulation: Preparation and potential as nuclear imaging agents
78. Nanoparticulate computed tomography contrast agents for blood pool and liver-spleen imaging
79. A new liposomal contrast medium for CT of the liver. An imaging study in a rabbit tumour model
80. CT visualization of blood pool in rats by using long-circulating, iodine-containing micelles